-
Peptide Reconstitution Guide
A step-by-step reference covering reconstitution, dosing math, syringe selection, and subcutaneous injection technique for lyophilized research peptides.
-
Retatrutide vs Semaglutide: What the Clinical Trial Data Shows
Semaglutide (the active compound in Ozempic and Wegovy) has dominated the GLP-1 research conversation since 2021. But a newer investigational compound — retatrutide — has produced clinical trial results that have drawn significant attention from the research community. This article summarizes the published data comparing these two compounds across efficacy, mechanism of action, and trial […]
-
GLOW Peptide Blend Research Protocol: GHK-Cu, BPC-157 & TB-500
The GLOW blend is a 70mg multi-peptide research formulation combining three compounds studied for tissue regeneration and repair: GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg). Each peptide operates through a distinct biological mechanism, and their combination is designed to address tissue repair through complementary pathways simultaneously. This page covers reconstitution, the standard daily research protocol, […]
-
Retatrutide Research Protocol: Reconstitution, Dosing Schedule & Storage Guide
Retatrutide (LY3437943) is an investigational triple-receptor agonist currently in Phase 3 clinical development. It targets GLP-1, GIP, and glucagon receptors simultaneously — a mechanism that distinguishes it from every other compound in its class. Phase 2 data published in the New England Journal of Medicine reported up to 24% body weight reduction at 48 weeks […]
-
BPC-157, TB-500, and GHK-Cu: What the Research Says About This Triple Combination
Three peptides with distinct but complementary mechanisms — and a growing body of research exploring what happens when you study all three together.
-
Peptides vs. Steroids: What the Science Actually Says
Peptides and anabolic steroids get lumped together constantly — but they are structurally distinct, work through entirely different mechanisms, and have very different research profiles. Here is what the science actually says.
-
Retatrutide: What Makes a Triple Agonist Different From Semaglutide and Tirzepatide
A look at the science behind GLP-1, GIP, and glucagon receptor co-agonism — and why researchers are paying close attention to retatrutide as the next frontier in metabolic research.
-
Built in the USA, Backed by Science: The Magnolia Research Labs Standard
A look at how Magnolia Research Labs approaches domestic manufacturing, third-party testing, and research-first formulation — and why that distinction matters.
Subtotal
$0.00
Shipping, taxes, and discounts calculated at checkout.
Your cart is currently empty!